RadioClash is the future of enhanced electroporation therapy

A revolutionary new treatment for cancer of the liver, pancreas, and bones. Effective, more affordable, faster recovery, minimally invasive.

Probe

News and Updates

Jul 2024Biotex Partnership

RadioClash has partnered with Houston based Biotex. With over 20 years of MedTech expertise, Biotex delivers strategic guidance and a proven track record of success. From development to commercialization, [they] help turn innovative ideas into market-ready medical devices.

Sep 2024RESI Boston BioTech Week

RadioClash was the winning company in our medical device pitch cohort. We also won 3rd place in the competition overall, and were the only company developing a medical device that placed in the Top 3.

Jan 2025RESI JPM in San Francisco

A premier international medtech and biotech event. RadioClash was the winning company in our medical device pitch cohort for the Innovator's Pitch Competition.

Jan 2025HBS New Ventures Competition

Harvard Business School - Advanced to Semifinals in Atlanta, GA

Mar 2025MedTech Innovator

Advanced to West Coast RoadTour pitch cohort with a successful pitch at UCLA in early March '25. We will receive new if we have made it to the Finals in June.

Our Team

John Qiao, MDFounder & Chief Executive Officer

Interventional Radiology UTHealth / MD Anderson Cancer Center

Duane Bester, BS EEChief Technology Officer

Electrical Engineer Software & Product Developer

Damir Ljuboja, MD, MBAChief Financial Officer

Interventional Radiology UTHealth / MD Anderson Cancer Center

Ashok Gowda, PhDBoard of Directors

President BioTex, Inc. Partner, MedTex Ventures

Leaflet Imagery © Mapbox

Headquarters

5813 Fulton StHouston, TX 77009
© 2025 RadioClash, Inc.